How often do you have to take semaglutide for weight loss?

Once a week, every week: semaglutide (Wegovy) is a 7-day injection or daily oral tablet — the injection is weekly; the dose level increases gradually over several months.
Injection day is flexible but fixed: you pick a day that suits your routine and keep it; you can shift it by up to two days if needed, following the Patient Information Leaflet guidance.
The starting dose is not the maintenance dose: the schedule begins at a lower strength to help your body adjust before moving toward the full therapeutic level.
Oral semaglutide has its own daily routine: the Wegovy tablet is taken once daily, first thing in the morning, on an empty stomach — a completely different rhythm from the weekly injection.

Semaglutide for weight loss is taken once a week, on the same chosen day each week. That weekly rhythm applies whether you are using Wegovy as an injection or, as of summer 2026, the new Wegovy tablet. The dose you start on changes over the first few months; the once-weekly schedule does not. Semaglutide is a prescription-only medicine, and a prescriber decides the right dose and pace of increase for your situation.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The semaglutide dosing journey: what actually happens week by week

Step 1, choosing your injection day and starting at 0.25 mg

The first practical question most people ask is not just "how often" but "which day?" With the Wegovy injection, you pick any day of the week that fits your life and repeat it every seven days, and our page on how often you take Wegovy walks through exactly how that weekly rhythm works in practice. Some people anchor it to a weekend morning when they are not rushing; others tie it to a midweek day so any mild nausea settles before the working week peaks. Consistency is what matters, not which day you land on.

The licensed starting dose for the injection is 0.25 mg, held for the first four weeks. The NHS medicines page for semaglutide describes this clearly: the low starting dose is designed to let your digestive system adjust before the dose climbs. At 0.25 mg you are not yet at a weight-loss dose; you are giving your body a settling-in period. Missing that step is one of the most common reasons people run into unnecessary side effects.

Semaglutide's long half-life is what makes once-weekly dosing possible, and if you want to understand how often you can take semaglutide and why that schedule is set the way it is, the medicine stays active in your system across the full seven days, which is why the rigid daily schedule of older appetite medicines is not needed here. You can read more about how the medicine works on our semaglutide overview page.

Step 2, moving through the titration schedule

After the first four weeks at 0.25 mg, the prescriber's plan typically steps the dose upward roughly every four weeks: 0.25 mg → 0.5 mg → 1.0 mg → 1.7 mg → 2.4 mg. The full pathway to the standard 2.4 mg maintenance dose therefore takes around 16 to 20 weeks. Throughout all of this, the injection frequency does not change. Every seven days, one pen, only the strength increases.

The MHRA's approval in April 2026 of a dedicated 7.2 mg single-dose pen extended the licensed maintenance ceiling further. That higher dose follows the same once-weekly injection frequency; it simply represents a longer titration journey for those for whom clinical assessment supports it. Our page covering how often you need to take Wegovy is worth reading if you want the full schedule laid out alongside the dose figures.

People sometimes ask whether they can take two doses close together if they miss one, or speed up the titration because they feel ready. The answer to both is the same: follow the Patient Information Leaflet and raise the question with your prescriber. Dose decisions (including timing of increases) sit with the clinician, not with how you feel week to week. If you are considering a private Wegovy prescription, it is worth knowing that at nume every repeat order is clinically reviewed before dispatch; dose increases are not automatic.

Step 3, settling into the maintenance routine

Once you reach your maintenance dose, the weekly injection becomes genuinely routine for most people. A lot of patients keep their pen in the fridge door and do the injection on Sunday evening after dinner, treating it like any other weekly health habit. The pen itself is pre-filled; there is no drawing up of liquid or measuring involved.

NICE's appraisal of semaglutide for weight management, TA875, notes that semaglutide for weight loss is recommended for a maximum of two years within a specialist weight management programme, so the "how often" question eventually extends to "for how long", and that is a conversation to have with your prescriber as treatment progresses.

The STEP 1 trial reported an average body-weight reduction of around 15% over 68 weeks at 2.4 mg weekly, published in the New England Journal of Medicine. Those results were achieved with the once-weekly dose schedule described above, alongside a reduced-calorie diet and increased activity. Semaglutide is not a standalone intervention; the injection is one part of a broader plan.

The Wegovy tablet: once daily, not once weekly

The Wegovy tablet (approved by the MHRA on 11 June 2026 as the first oral GLP-1 medicine licensed for weight management in the UK) works on a different schedule entirely. It is taken once daily, not once weekly. The routine matters: the tablet is taken first thing in the morning, on an empty stomach, with a small amount of plain water. You then wait at least 30 minutes before eating, drinking anything other than water, or taking other medicines.

The dose ladder for the tablet is 1.5 mg → 4 mg → 9 mg → 25 mg, with a minimum of one month at each level before moving up. There is no refrigeration needed, which makes it a practical option for people who travel frequently or find injection storage difficult. Our Wegovy tablet page covers what the oral option involves in more detail.

If you are weighing up which format suits your life, a prescriber can help you think through the practicalities. Speak to our prescribers through a free consultation at nume to explore which option fits your circumstances and medical history.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions